AEVIS VICTORIA SA joins SXI Life Sciences Index (SLIFE) and SXI Bio+Medtech Index (SBIOM)

EQS Group-Ad-hoc: AEVIS VICTORIA SA / Key word(s): Miscellaneous

2016-09-19 / 07:00
Release of an ad hoc announcement pursuant to Art. 53 KR.


Press release

Fribourg, 19 September 2016

AEVIS VICTORIA SA joins SXI Life Sciences Index (SLIFE) and SXI Bio+Medtech Index (SBIOM)

The AEVIS VICTORIA SA nominal shares are listed on the Swiss Reporting Standard of the SIX Swiss Exchange (securities number: 1248819, ISIN: CH0012488190, Bloomberg: AEVS SW Equity, Reuters: AEVS.S.). As of today, AEVIS VICTORIA SA shares are part of the indices SXI Life Sciences Index (SLIFE) and SXI Bio+Medtech Index (SBIOM).

For further information:
AEVIS VICTORIA SA Media and Investor Relations: c/o Dynamics Group, Zurich
Philippe R. Blangey, prb@dynamicsgroup.ch, +41 (0) 43 268 32 35 or +41 (0) 79 785 46 32
Séverine Van der Schueren, svanderschueren@aevis.com, +41 (0) 26 350 02 02

AEVIS VICTORIA SA – Investing for a better life
AEVIS VICTORIA SA invests in services to people, healthcare, hospitality, life sciences and lifestyle. AEVIS′s main shareholdings are Swiss Medical Network SA, the second largest group of private hospitals in Switzerland, Victoria-Jungfrau Collection AG, a luxury hotel group managing four luxury hotels in Switzerland, a hospitals and hospitality real estate division comprising 40 properties, Medgate, the leading telemedicine provider in Switzerland, and NESCENS SA, a brand dedicated to better aging. AEVIS is listed on the Swiss Reporting Standard of the SIX Swiss Exchange (AEVS.SW). www.aevis.com.


End of ad hoc announcement


show this